Senate interest in $35 insulin price cap grows

Key facts

• Bipartisan support is growing in the Senate for legislation to cap insulin costs.
• The proposed legislation would limit out-of-pocket insulin expenses to $35 for individuals with private health insurance.

Bipartisan support is growing in the Senate for legislation that would limit how much people with private health insurance pay for insulin. Senator Susan Collins (R-Maine) is among those showing interest in a $35 insulin price cap.